|May. 1, 2017|
Direx announced today that it has received approval
from the Saudi Food and Drug Administration (SFDA) to market its Renova system
in Saudia Arabia for the treatment of Erectile Dysfunction.
Renova is currently the only fully approved device
offering shockwave therapy for patients suffering from ED. "Considerable
interest has been expressed by local physicians who are eager to offer this
treatment to their patients" noted the local representative.
Renova will be presented at the upcoming Middle East Society of Sexual Medicine
(MESSM), to take place September 14-16, in Abu Dhabi, UAE.
DirexGroup specializes in introducing innovative high-technology devices for
urologists in all worldwide markets. DirexGroup, established over 30 years ago,
has continuously extended its worldwide presence in numerous countries and
markets. DirexGroup has put its emphasis on the field of urology and offers
urologists and medical centers various equipment and service solutions to their
clinical and economic needs. Our products are characterized by reliability,
modularity and transportability combined with cost effectiveness and ease of
use. A worldwide network of committed service centers assures competent support
and maintenance. Contact DirexGroup at: email@example.com